Veracyte Income Statement 2025-2010 | VCYT

Brief overview of revenue and earnings at Veracyte

The conclusions below are based on five years of reported results. Revenue at Veracyte moved from 117 million dollars in 2020 to 517 million dollars in 2025. Overall revenue changed by +340.2%, equal to an annualized rate of about 34.5%. The annual growth rate indicates an exceptionally strong top-line trend.

At the gross-profit level, the result moved from 76 million dollars to 363 million dollars, a change of +376.8%. At the margin level, the figure shifted from 64.7% to 70.1%. The expansion indicates stronger pricing power or better control of direct costs.

EBITDA was −$27.4 million at the beginning and $79.2 million at the end of the period (+388.5%). EBITDA expanded faster than the top line. At the operating-margin level, the figure shifted from −23.4% to 15.3%. The company improved its ability to convert sales into EBITDA.

The net financial result changed from 0 dollars to 66.4 million dollars. The business moved out of a loss and ended the period with a profit.

The market value of the business moved from 3.1 billion dollars to 3 billion dollars, or −2.1%. The valuation did not keep pace with the reported progress.

Financial takeaway

The five-year financial profile is predominantly positive. The strongest signals are positive operating leverage, improving gross profitability and a larger revenue base. The key question is whether sales can be converted into sustainable profit.